To determine whether these changes in ICOS expression in the peripheral blood were also reflected in the tumor, we harvested tumors at day 21 (day 7 following radiation therapy) to evaluate ICOS expression on tumor-infiltrating T cells by flow cytometry. The gene discussed is ICOS; the disease is neoplasm.